US-based virtual care clinic Midi Health has secured $60m in a Series B funding round to fund its efforts to improve women’s healthcare.
The round was led by Emerson Collective and included contributions from Google Ventures (GV), which led a previous funding round for Midi Health.
Go deeper with GlobalData
Other investors in this round included SemperVirens, Memorial Hermann, Felicis, Able Partners, Black Angel Group, Icon Ventures, Gingerbread Capital, G9 and Operator Collective.
These new investors join Midi Health’s existing backers, which include Steel Sky Ventures, Anne Wojcicki, Muse Capital, F7, Avestria, 1843 Capital, K50 Ventures and Susan Wojcicki.
The latest investment brings the company’s total funding to $100m since its establishment in 2021.
Based in California, Midi Health aims to close the gap in women’s healthcare by offering personalised care plans to women navigating midlife hormonal changes and beyond.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThese plans include a combination of hormonal and non-hormonal medications, along with supplements and other lifestyle coaching support.
All the company’s services are covered by insurance and accessible via telehealth visits and round-the-clock messaging.
Midi Health plans to use the Series B funding to expand its insurance coverage, as well as hire and train an additional 150 clinicians by the end of this year.
The company will also diversify its service offerings, initiate enhanced conversation efforts around midlife women’s healthcare, and scale up its operations to support more than one million women each year by 2029.
Midi Health CEO and co-founder Joanna Strober said: “Midi takes a multi-symptom, holistic approach to care designed to help women live their best, most productive and fulfilling lives—whether that involves medication, lifestyle coaching, natural supplements, or other support.
“Our goal now is to expand services and scope to continue this comprehensive, personalised care far beyond menopause.”
Midi Health recently expanded its footprint in the employer care space by partnering with caregiving platform Cleo.
